Blonder Tongue Laboratories (BDRL) 10-Q 2022 Q2 Quarterly report

Exhibit 32.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

To the knowledge of each of the undersigned, this Report on Form 10-Q for the quarter ended June 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Blonder Tongue Laboratories, Inc. for the applicable reporting period.

Date: August 15, 2022	By:	/s/ Edward R. Grauch
		Edward R. Grauch, Chief Executive Officer
	By:	/s/ Eric Skolnik
		Eric Skolnik, Chief Financial Officer